From Black Box to Revenue Control
EXECUTIVE SUMMARY
A multi-location rheumatology practice in Central Florida, specializing in complex autoimmune and musculoskeletal care, was losing revenue it couldn’t see. High-value biologic claims were breaking down silently, denials were compounding across treatment cycles, and no one had visibility into where the money was going.
By partnering with EMPClaims, the practice cut its claim denial rate in half — from 40% to 20–25% — and gained full transparency into its revenue lifecycle for the first time.
| Stat | Label |
|---|---|
| 50% | Denial Rate Reduction |
| 40% → 20–25% | Claims Now Processed Cleanly |
The Challenge
Biologic Revenue at Risk
Complex HCPCS drug codes, dosage unit billing, and modifier requirements were generating repeat denials — but without pattern-level visibility, the same errors compounded month over month.
Authorization Gaps
Manual tracking led to expired approvals mid-treatment and services rendered without confirmed authorization.
Denial Patterns in the Dark
With denial rates at 40%, claims were being reworked individually with no root-cause analysis. The practice was fighting the same fires on repeat.
Cash Flow Paralysis
Unresolved claims accumulated in AR with no structured follow-up and no visibility into what was recoverable.
The Solution: People + Process + AI
Revenue Visibility
Deployed the Wurklist platform to replace fragmented workflows with real-time dashboards — claim status, denial trends, payer behavior, and AR aging visible for the first time.
AI-Powered Claim Integrity
Implemented the Billing Rules Engine with rheumatology-specific rules — CPT/ICD cross-checks, HCPCS drug code validation, and modifier logic scrubbing every claim before submission. Errors caught before they become denials.
Authorization Lifecycle Control
Replaced manual tracking with structured workflows — authorizations verified before service, approval limits tracked across treatment cycles, expirations flagged early.
Aggressive AR Recovery
Analyzed denial patterns at the root-cause level to stop repeat denials at the source. Structured follow-up cadence on every outstanding claim. No silent write-offs.
Key Performance Metrics
| Metric | Before EMPClaims | After EMPClaims | The Impact |
|---|---|---|---|
| Claim Denial Rate | 40% | 20–25% | 50% reduction — fewer denials, less rework |
| Days in AR | No structured tracking | Active follow-up cadence | Every outstanding claim owned and worked |
Business Impact
Full Revenue Visibility
Real-time dashboards that drive action, not backward-looking reports
A Strategic Partner
Weekly touchpoints, proactive risk identification, embedded financial oversight
Clinical Focus Restored
Providers treating patients, EMPClaims protecting the revenue
"Rheumatology revenue is built on consistency and discipline, not speed. Payers remember patterns - and so do we."
People + Process + AI. No Claim Left Behind.